Research and Markets has announced the addition of the "Global Radiotherapy Market - Industry Trends and Forecast to 2024" report to their offering.

Global Radiotherapy Market Is Expected to Reach USD 5.3 Billion by 2024, at a CAGR of 7.5% in the Forecast Period 2017 to 2024

The world is focused upon developing solutions and cure to cancer by destroying primary and secondary tumours that cause metastasis. In current healthcare scenario localized treatment of tumours the only efficient treatment for tumours. Radiosurgery is used alongside surgery or separately to treat cancer for a long time. More than 75% of the cancer patient population is expected to take radiosurgery in some point of their disease prognosis.

The global radiotherapy market is segmented based on therapy, the market is segmented into external beam radiotherapy, internal beam radiotherapy, and systemic radiation therapy.

Based on product type the global radiotherapy market is segmented into EBRT equipment's, and IBRT equipment's.

The External Beam Radiotherapy (EBRT) products are further segmented into cyberknife, gammaknife, LINAC, Proton Beam (Cyclotron, Synclotron). The Internal Beam Radiotherapy (IBRT) is segmented into seeds, afterloaders and others.

The global radiotherapy market is also segmented based on indication into cancer of different organs such as brain tumour, spine cancer, lung cancer, liver cancer, breast cancer, prostate cancer and others.

Based on mode of administration the market is segmented into skin, circulatory, organs and central nervous system.

Major Players Operating in this market:

  • Brainlab AG
  • C. R. Bard Inc.
  • CIVCO Medical Solutions
  • Hitachi Ltd.
  • IsoRay Medical Inc.
  • Mevion Medical Systems Inc.
  • Mitsubishi Electric Corporation
  • Nordion Inc.
  • PRECISIS AG
  • ProNova Solutions LLC
  • ProTom International
  • RaySearch Laboratories AB
  • Sumitomo Heavy Industries Ltd.
  • Technicas Radiofiscas S.L.

For more information about this report visit http://www.researchandmarkets.com/research/vmn7lf/global